Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 7 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Immunome Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 35 | 35 | 0 |
| Shares | 1.95M | 2.36M | +413.9K (+21.2%) |
| Value | $15.4M | $19.7M | +$4.23M (+27.4%) |
New holders (9)
Institutions that held Immunome Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Price T Rowe Associates Inc | 173,630 | $1.45M | 0.00% |
| TD Asset Management Inc | 127,280 | $1.06M | 0.00% |
| Manufacturers Life Insurance Company, The | 53,746 | $448.8K | 0.00% |
| Acadian Asset Management LLC | 49,712 | $414.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 18,201 | $152.0K | 0.00% |
| Dorsey Wright & Associates | 3,100 | $25.9K | 0.01% |
| Cubist Systematic Strategies, LLC | 299 | $2.50K | 0.00% |
| Bank of America Corp | 54 | $451 | 0.00% |
| Qube Research & Technologies Ltd | 10 | $84 | 0.00% |
Sold out (9)
Institutions that held Immunome Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cerity Partners LLC | 67,126 | $531.0K |
| Sterling Investment Advisors, Ltd. | 21,627 | $171.1K |
| Heron Bay Capital Management | 13,139 | $103.9K |
| Group One Trading, L.P. | 7,705 | $60.9K |
| FNY Investment Advisers, LLC | 3,500 | $27.0K |
| Tower Research Capital LLC (TRC) | 3,040 | $24.0K |
| Natixis | 3,000 | $23.7K |
| JPMorgan Chase & Co | 915 | $7.24K |
| Cutler Group LP | 600 | $4.00K |